DEVON PARK BIOVENTURES
Devon Park Bioventures, located in the Philadelphia metropolitan area, is within driving distance of the headquarters of many of the worlds
DEVON PARK BIOVENTURES
Founded:
2006-01-01
Status:
Closed
Technology used in webpage:
Microsoft Azure DNS Network Solutions DNS Network Solutions Securence
Current Employees Featured
Christopher Moller
Christopher Moller General Partner @ Devon Park BioVentures General Partner
Devang Kantesaria
Devang Kantesaria General Partner @ Devon Park BioVentures General Partner
Marc Ostro
Marc Ostro General Partner @ Devon Park BioVentures General Partner
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-04-10 | Cardeas Pharma | Devon Park BioVentures investment in Series B - Cardeas Pharma | 37.5 M USD |
2014-05-16 | Proteon Therapeutics | Devon Park BioVentures investment in Series D - Proteon Therapeutics | 45 M USD |
2014-03-05 | ZS Pharma | Devon Park BioVentures investment in Series D - ZS Pharma | 55 M USD |
2013-09-27 | Inotek Pharmaceuticals | Devon Park BioVentures investment in Venture Round - Inotek Pharmaceuticals | 21 M USD |
2013-09-27 | Inotek Pharmaceuticals | Devon Park BioVentures investment in Debt Financing - Inotek Pharmaceuticals | 7 M USD |
2013-08-22 | MicuRx Pharmaceuticals | Devon Park BioVentures investment in Series B - MicuRx Pharmaceuticals | 25 M USD |
2012-10-23 | ZS Pharma | Devon Park BioVentures investment in Series C - ZS Pharma | 46 M USD |
2012-06-07 | Cardeas Pharma | Devon Park BioVentures investment in Series A - Cardeas Pharma | 8.5 M USD |
2012-02-22 | Vascular Magnetics | Devon Park BioVentures investment in Series A - Vascular Magnetics | 7 M USD |
2011-08-12 | Proteon Therapeutics | Devon Park BioVentures investment in Series C - Proteon Therapeutics | 15.2 M USD |